{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:26:23Z","timestamp":1772749583492,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072821"],"award-info":[{"award-number":["82072821"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92059112"],"award-info":[{"award-number":["92059112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010229","name":"Natural Science Foundation of Tianjin Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["20SJKJGG250"],"award-info":[{"award-number":["20SJKJGG250"]}],"id":[{"id":"10.13039\/501100010229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06393-7","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T07:52:45Z","timestamp":1744271565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["SIGMAR1 screened by a GPCR-related classifier regulates endoplasmic reticulum stress in bladder cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Jingming","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengnan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0952-2257","authenticated-orcid":false,"given":"Bing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"issue":"1","key":"6393_CR1","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"6393_CR2","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: A review. JAMA. 2020;324(19):1980\u201391.","journal-title":"JAMA"},{"issue":"5","key":"6393_CR3","first-page":"404","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70(5):404\u201323.","journal-title":"CA Cancer J Clin"},{"issue":"4S","key":"6393_CR4","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.ucl.2020.10.005","volume":"47","author":"SS Nair","year":"2020","unstructured":"Nair SS, Weil R, Dovey Z, Davis A, Tewari AK. The tumor microenvironment and immunotherapy in prostate and bladder cancer. Urol Clin North Am. 2020;47(4S):e17\u201354.","journal-title":"Urol Clin North Am"},{"issue":"10","key":"6393_CR5","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1073\/pnas.1721896115","volume":"115","author":"N Van Eps","year":"2018","unstructured":"Van Eps N, Altenbach C, Caro LN, Latorraca NR, Hollingsworth SA, Dror RO, Ernst OP, Hubbell WL. G(i)- and G(s)-coupled GPCRs show different modes of G-protein binding. Proc Natl Acad Sci U S A. 2018;115(10):2383\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6393_CR6","doi-asserted-by":"crossref","unstructured":"Bar-Shavit R, Maoz M, Kancharla A, Nag JK, Agranovich D, Grisaru-Granovsky S, Uziely B. G Protein-Coupled receptors in cancer. Int J Mol Sci 2016, 17(8).","DOI":"10.3390\/ijms17081320"},{"key":"6393_CR7","doi-asserted-by":"crossref","unstructured":"Longhitano L, Forte S, Orlando L, Grasso S, Barbato A, Vicario N, Parenti R, Fontana P, Amorini AM, Lazzarino G et al. The crosstalk between GPR81\/IGFBP6 promotes breast cancer progression by modulating lactate metabolism and oxidative stress. Antioxid (Basel) 2022, 11(2).","DOI":"10.3390\/antiox11020275"},{"issue":"3","key":"6393_CR8","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1073\/pnas.1614035114","volume":"114","author":"P Chen","year":"2017","unstructured":"Chen P, Zuo H, Xiong H, Kolar MJ, Chu Q, Saghatelian A, Siegwart DJ, Wan Y. Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis. Proc Natl Acad Sci U S A. 2017;114(3):580\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"6393_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/gutjnl-2020-323363","volume":"71","author":"E Pagano","year":"2022","unstructured":"Pagano E, Elias JE, Schneditz G, Saveljeva S, Holland LM, Borrelli F, Karlsen TH, Kaser A, Kaneider NC. Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment. Gut. 2022;71(3):509\u201320.","journal-title":"Gut"},{"key":"6393_CR10","doi-asserted-by":"publisher","first-page":"705575","DOI":"10.3389\/fphys.2021.705575","volume":"12","author":"R Aishwarya","year":"2021","unstructured":"Aishwarya R, Abdullah CS, Morshed M, Remex NS, Bhuiyan MS. Sigmar1\u2019s molecular, cellular, and biological functions in regulating cellular pathophysiology. Front Physiol. 2021;12:705575.","journal-title":"Front Physiol"},{"issue":"7","key":"6393_CR11","doi-asserted-by":"publisher","first-page":"e15373","DOI":"10.15252\/emmm.202115373","volume":"14","author":"X Wei","year":"2022","unstructured":"Wei X, Zheng Z, Feng Z, Zheng L, Tao S, Zheng B, Huang B, Zhang X, Liu J, Chen Y, et al. Sigma-1 receptor attenuates osteoclastogenesis by promoting ER-associated degradation of SERCA2. EMBO Mol Med. 2022;14(7):e15373.","journal-title":"EMBO Mol Med"},{"key":"6393_CR12","doi-asserted-by":"publisher","first-page":"173614","DOI":"10.1016\/j.ejphar.2020.173614","volume":"889","author":"Y Fo","year":"2020","unstructured":"Fo Y, Zhang C, Chen X, Liu X, Ye T, Guo Y, Qu C, Shi S, Yang B. Chronic sigma-1 receptor activation ameliorates ventricular remodeling and decreases susceptibility to ventricular arrhythmias after myocardial infarction in rats. Eur J Pharmacol. 2020;889:173614.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"6393_CR13","first-page":"529","volume":"29","author":"S Couly","year":"2020","unstructured":"Couly S, Khalil B, Viguier V, Roussel J, Maurice T, Lievens JC. Sigma-1 receptor is a key genetic modulator in amyotrophic lateral sclerosis. Hum Mol Genet. 2020;29(4):529\u201340.","journal-title":"Hum Mol Genet"},{"key":"6393_CR14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fnins.2019.00862","volume":"13","author":"DA Ryskamp","year":"2019","unstructured":"Ryskamp DA, Korban S, Zhemkov V, Kraskovskaya N, Bezprozvanny I. Neuronal Sigma-1 receptors: signaling functions and protective roles in neurodegenerative diseases. Front Neurosci. 2019;13:862.","journal-title":"Front Neurosci"},{"key":"6393_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.expneurol.2018.07.002","volume":"308","author":"DY Liu","year":"2018","unstructured":"Liu DY, Chi TY, Ji XF, Liu P, Qi XX, Zhu L, Wang ZQ, Li L, Chen L, Zou LB. Sigma-1 receptor activation alleviates blood-brain barrier dysfunction in vascular dementia mice. Exp Neurol. 2018;308:90\u20139.","journal-title":"Exp Neurol"},{"key":"6393_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3389\/fphar.2019.00687","volume":"10","author":"SG Quadir","year":"2019","unstructured":"Quadir SG, Cottone P, Sabino V. Role of Sigma receptors in alcohol addiction. Front Pharmacol. 2019;10:687.","journal-title":"Front Pharmacol"},{"issue":"11","key":"6393_CR17","doi-asserted-by":"publisher","first-page":"7349","DOI":"10.1111\/jcmm.14594","volume":"23","author":"T Bai","year":"2019","unstructured":"Bai T, Lei P, Zhou H, Liang R, Zhu R, Wang W, Zhou L, Sun Y. Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells. J Cell Mol Med. 2019;23(11):7349\u201359.","journal-title":"J Cell Mol Med"},{"key":"6393_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.preteyeres.2018.07.003","volume":"67","author":"SB Smith","year":"2018","unstructured":"Smith SB, Wang J, Cui X, Mysona BA, Zhao J, Bollinger KE. Sigma 1 receptor: A novel therapeutic target in retinal disease. Prog Retin Eye Res. 2018;67:130\u201349.","journal-title":"Prog Retin Eye Res"},{"issue":"23","key":"6393_CR19","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.1158\/0008-5472.CAN-18-0689","volume":"78","author":"L Xu","year":"2018","unstructured":"Xu L, Deng C, Pang B, Zhang X, Liu W, Liao G, Yuan H, Cheng P, Li F, Long Z, et al. TIP: A web server for resolving tumor immunophenotype profiling. Cancer Res. 2018;78(23):6575\u201380.","journal-title":"Cancer Res"},{"issue":"1","key":"6393_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13020-023-00818-5","volume":"18","author":"J Zhuang","year":"2023","unstructured":"Zhuang J, Mo J, Huang Z, Yan Y, Wang Z, Cao X, Yang C, Shen B, Zhang F. Mechanisms of Xiaozheng Decoction for anti-bladder cancer effects via affecting the GSK3beta\/beta-catenin signaling pathways: a network pharmacology-directed experimental investigation. Chin Med. 2023;18(1):104.","journal-title":"Chin Med"},{"issue":"8","key":"6393_CR21","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1111\/andr.13293","volume":"10","author":"J Zhuang","year":"2022","unstructured":"Zhuang J, Gao P, Chen H, Fang Z, Zheng J, Zhu D, Hou J. Extracellular vesicles from human urine-derived stem cells merged in hyaluronic acid ameliorate erectile dysfunction in type 2 diabetic rats by Glans administration. Andrology. 2022;10(8):1673\u201386.","journal-title":"Andrology"},{"issue":"2","key":"6393_CR22","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41417-022-00552-4","volume":"30","author":"P Borde","year":"2023","unstructured":"Borde P, Cosgrove N, Charmsaz S, Safrany ST, Young L. An investigation of Sigma-1 receptor expression and ligand-induced Endoplasmic reticulum stress in breast cancer. Cancer Gene Ther. 2023;30(2):368\u201374.","journal-title":"Cancer Gene Ther"},{"issue":"4","key":"6393_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s10142-024-01414-y","volume":"24","author":"M Kong","year":"2024","unstructured":"Kong M, Chen Z, Lin Z, Yin P, Zhao Q. SIGMAR1 targets AMPK\/ULK1 pathway to inhibit SH-SY5Y cell apoptosis by regulating Endoplasmic reticulum stress and autophagy. Funct Integr Genomics. 2024;24(4):134.","journal-title":"Funct Integr Genomics"},{"key":"6393_CR24","doi-asserted-by":"publisher","first-page":"115856","DOI":"10.1016\/j.taap.2021.115856","volume":"435","author":"H Ghafoor","year":"2022","unstructured":"Ghafoor H, Chu H, Huang J, Chen M, Wang S, Wang J, Chao J. ZC3H4 promotes pulmonary fibrosis via an ER stress-related positive feedback loop. Toxicol Appl Pharmacol. 2022;435:115856.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"6393_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","volume":"15","author":"MA Knowles","year":"2015","unstructured":"Knowles MA, Hurst CD. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer. 2015;15(1):25\u201341.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"6393_CR26","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41419-022-04979-3","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Sheng J, Hu S, Cui Y, Xiao J, Yu W, Peng J, Han W, He Q, Fan Y, et al. Estrogen and G protein-coupled Estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis. Cell Death Dis. 2022;13(6):533.","journal-title":"Cell Death Dis"},{"key":"6393_CR27","doi-asserted-by":"publisher","first-page":"106279","DOI":"10.1016\/j.phrs.2022.106279","volume":"182","author":"S Lyu","year":"2022","unstructured":"Lyu S, Zhang X, Tu Z, Zhou H, Ke X, Qu Y. GPR108 is required for gambogic acid inhibiting NF-kappaB signaling in cancer. Pharmacol Res. 2022;182:106279.","journal-title":"Pharmacol Res"},{"issue":"26","key":"6393_CR28","doi-asserted-by":"publisher","first-page":"e2200562","DOI":"10.1002\/advs.202200562","volume":"9","author":"Y Xiong","year":"2022","unstructured":"Xiong Y, Ke R, Zhang Q, Lan W, Yuan W, Chan KNI, Roussel T, Jiang Y, Wu J, Liu S, et al. Small activating RNA modulation of the G Protein-Coupled receptor for cancer treatment. Adv Sci (Weinh). 2022;9(26):e2200562.","journal-title":"Adv Sci (Weinh)"},{"issue":"Pt 2","key":"6393_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.semcancer.2022.09.005","volume":"86","author":"T Li","year":"2022","unstructured":"Li T, Qiao T. Unraveling tumor microenvironment of small-cell lung cancer: implications for immunotherapy. Semin Cancer Biol. 2022;86(Pt 2):117\u201325.","journal-title":"Semin Cancer Biol"},{"key":"6393_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","volume":"18","author":"MH Sherman","year":"2023","unstructured":"Sherman MH, Beatty GL. Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance. Annu Rev Pathol. 2023;18:123\u201348.","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"6393_CR31","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/jop.13376","volume":"52","author":"T Zhang","year":"2023","unstructured":"Zhang T, Liu G, Zhang J, Chen S, Deng Z, Xie M. GPRASP1 is a candidate anti-oncogene and correlates with immune microenvironment and immunotherapeutic efficiency in head and neck cancer. J Oral Pathol Med. 2023;52(3):232\u201344.","journal-title":"J Oral Pathol Med"},{"issue":"11","key":"6393_CR32","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1038\/s41418-021-00801-3","volume":"28","author":"S Dasgupta","year":"2021","unstructured":"Dasgupta S, Ghosh T, Dhar J, Bhuniya A, Nandi P, Das A, Saha A, Das J, Guha I, Banerjee S, et al. RGS5-TGFbeta-Smad2\/3 axis switches pro- to anti-apoptotic signaling in tumor-residing pericytes, assisting tumor growth. Cell Death Differ. 2021;28(11):3052\u201376.","journal-title":"Cell Death Differ"},{"issue":"17","key":"6393_CR33","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.18632\/aging.204279","volume":"14","author":"J Chen","year":"2022","unstructured":"Chen J, Wang K, Ye S, Meng X, Jia X, Huang Y, Ma Q. Tyrosine kinase receptor RON activates MAPK\/RSK\/CREB signal pathway to enhance CXCR4 expression and promote cell migration and invasion in bladder cancer. Aging. 2022;14(17):7093\u2013108.","journal-title":"Aging"},{"issue":"1","key":"6393_CR34","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1080\/21655979.2021.1971035","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Lou W, Chen G, Ding B, Kuang J, Zhang Y, Wang C, Duan S, Deng Y, Lu X. Genome-wide screening for the G-protein-coupled receptor (GPCR) pathway-related therapeutic gene RGS19 (regulator of G protein signaling 19) in bladder cancer. Bioengineered. 2021;12(1):5892\u2013903.","journal-title":"Bioengineered"},{"key":"6393_CR35","doi-asserted-by":"publisher","first-page":"42157","DOI":"10.1038\/srep42157","volume":"7","author":"A Bettiga","year":"2017","unstructured":"Bettiga A, Aureli M, Colciago G, Murdica V, Moschini M, Luciano R, Canals D, Hannun Y, Hedlund P, Lavorgna G, et al. Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism. Sci Rep. 2017;7:42157.","journal-title":"Sci Rep"},{"issue":"6","key":"6393_CR36","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/bab.1329","volume":"62","author":"Y Du","year":"2015","unstructured":"Du Y, Bi W, Zhang F, Wu W, Xia S, Liu H. G-protein-coupled receptor 137 accelerates proliferation of urinary bladder cancer cells in vitro. Biotechnol Appl Biochem. 2015;62(6):855\u201360.","journal-title":"Biotechnol Appl Biochem"},{"issue":"10","key":"6393_CR37","doi-asserted-by":"publisher","first-page":"24319","DOI":"10.3390\/ijms161024319","volume":"16","author":"X Zhang","year":"2015","unstructured":"Zhang X, Liu D, Hayashida Y, Okazoe H, Hashimoto T, Ueda N, Sugimoto M, Kakehi Y. G Protein-Coupled receptor 87 (GPR87) promotes cell proliferation in human bladder cancer cells. Int J Mol Sci. 2015;16(10):24319\u201331.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6393_CR38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12943-022-01597-7","volume":"21","author":"I Heidegger","year":"2022","unstructured":"Heidegger I, Fotakis G, Offermann A, Goveia J, Daum S, Salcher S, Noureen A, Timmer-Bosscha H, Schafer G, Walenkamp A, et al. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4\/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer. Mol Cancer. 2022;21(1):132.","journal-title":"Mol Cancer"},{"issue":"1","key":"6393_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-023-01337-3","volume":"8","author":"R Zhang","year":"2023","unstructured":"Zhang R, Dong M, Tu J, Li F, Deng Q, Xu J, He X, Ding J, Xia J, Sheng D, et al. PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway. Signal Transduct Target Ther. 2023;8(1):97.","journal-title":"Signal Transduct Target Ther"},{"key":"6393_CR40","doi-asserted-by":"crossref","unstructured":"Bang L, Shivakumar M, Garg T, Kim D. Genetic analysis reveals rare variants in T-Cell response gene MR1 associated with poor overall survival after urothelial cancer diagnosis. Cancers (Basel) 2021, 13(8).","DOI":"10.3390\/cancers13081864"},{"issue":"2","key":"6393_CR41","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.juro.2010.09.082","volume":"185","author":"PC Black","year":"2011","unstructured":"Black PC, Brown GA, Dinney CP, Kassouf W, Inamoto T, Arora A, Gallagher D, Munsell MF, Bar-Eli M, McConkey DJ, et al. Receptor heterodimerization: a new mechanism for platelet-derived growth factor induced resistance to anti-epidermal growth factor receptor therapy for bladder cancer. J Urol. 2011;185(2):693\u2013700.","journal-title":"J Urol"},{"issue":"22","key":"6393_CR42","doi-asserted-by":"publisher","first-page":"10524","DOI":"10.1158\/0008-5472.CAN-05-1536","volume":"65","author":"W Kassouf","year":"2005","unstructured":"Kassouf W, Dinney CP, Brown G, McConkey DJ, Diehl AJ, Bar-Eli M, Adam L. Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of gefitinib in bladder cancer cells. Cancer Res. 2005;65(22):10524\u201335.","journal-title":"Cancer Res"},{"key":"6393_CR43","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.12659\/MSM.913746","volume":"25","author":"Y Tan","year":"2019","unstructured":"Tan Y, Zhang T, Zhou L, Liu S, Liang C. MiR-34b-3p represses the Multidrug-Chemoresistance of bladder cancer cells by regulating the CCND2 and P2RY1 genes. Med Sci Monit. 2019;25:1323\u201335.","journal-title":"Med Sci Monit"},{"issue":"1","key":"6393_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/cncr.27661","volume":"119","author":"TJ Yates","year":"2013","unstructured":"Yates TJ, Knapp J, Gosalbez M, Lokeshwar SD, Gomez CS, Benitez A, Ekwenna OO, Young EE, Manoharan M, Lokeshwar VB. C-X-C chemokine receptor 7: a functionally associated molecular marker for bladder cancer. Cancer. 2013;119(1):61\u201371.","journal-title":"Cancer"},{"issue":"2","key":"6393_CR45","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bcp.2012.04.007","volume":"84","author":"M Hao","year":"2012","unstructured":"Hao M, Zheng J, Hou K, Wang J, Chen X, Lu X, Bo J, Xu C, Shen K, Wang J. Role of chemokine receptor CXCR7 in bladder cancer progression. Biochem Pharmacol. 2012;84(2):204\u201314.","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"6393_CR46","doi-asserted-by":"publisher","first-page":"e3141","DOI":"10.1038\/cddis.2017.544","volume":"8","author":"A Feliciano","year":"2017","unstructured":"Feliciano A, Garcia-Mayea Y, Jubierre L, Mir C, Hummel M, Castellvi J, Hernandez-Losa J, Paciucci R, Sansano I, Sun Y, et al. miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer. Cell Death Dis. 2017;8(10):e3141.","journal-title":"Cell Death Dis"},{"issue":"13","key":"6393_CR47","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1158\/0008-5472.CAN-23-2314","volume":"84","author":"D Huang","year":"2024","unstructured":"Huang D, Yu Z, Lu H, Jiang P, Qian X, Han Y, Qian P. Adhesion GPCR ADGRE2 maintains proteostasis to promote progression in acute myeloid leukemia. Cancer Res. 2024;84(13):2090\u2013108.","journal-title":"Cancer Res"},{"key":"6393_CR48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fonc.2018.00033","volume":"8","author":"L Weber","year":"2018","unstructured":"Weber L, Massberg D, Becker C, Altmuller J, Ubrig B, Bonatz G, Wolk G, Philippou S, Tannapfel A, Hatt H, et al. Olfactory receptors as biomarkers in human breast carcinoma tissues. Front Oncol. 2018;8:33.","journal-title":"Front Oncol"},{"issue":"1","key":"6393_CR49","doi-asserted-by":"publisher","first-page":"13736","DOI":"10.1038\/s41598-019-50085-4","volume":"9","author":"S Masjedi","year":"2019","unstructured":"Masjedi S, Zwiebel LJ, Giorgio TD. Olfactory receptor gene abundance in invasive breast carcinoma. Sci Rep. 2019;9(1):13736.","journal-title":"Sci Rep"},{"issue":"1","key":"6393_CR50","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12885-024-12234-5","volume":"24","author":"L Zhou","year":"2024","unstructured":"Zhou L, Zeng Y, Liu Y, Du K, Luo Y, Dai Y, Pan W, Zhang L, Zhang L, Tian F, et al. Cellular senescence and metabolic reprogramming model based on bulk\/single-cell RNA sequencing reveals PTGER4 as a therapeutic target for CcRCC. BMC Cancer. 2024;24(1):451.","journal-title":"BMC Cancer"},{"issue":"3","key":"6393_CR51","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/1078-0432.CCR-21-0299","volume":"28","author":"S Peng","year":"2022","unstructured":"Peng S, Hu P, Xiao YT, Lu W, Guo D, Hu S, Xie J, Wang M, Yu W, Yang J, et al. Single-Cell analysis reveals EP4 as a target for restoring T-Cell infiltration and sensitizing prostate cancer to immunotherapy. Clin Cancer Res. 2022;28(3):552\u201367.","journal-title":"Clin Cancer Res"},{"key":"6393_CR52","doi-asserted-by":"publisher","first-page":"1090040","DOI":"10.3389\/fimmu.2023.1090040","volume":"14","author":"S Zhao","year":"2023","unstructured":"Zhao S, Chi H, Yang Q, Chen S, Wu C, Lai G, Xu K, Su K, Luo H, Peng G, et al. Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson\u2019s disease. Front Immunol. 2023;14:1090040.","journal-title":"Front Immunol"},{"issue":"4","key":"6393_CR53","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jordao MJC, Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Discov. 2021;11(4):933\u201359.","journal-title":"Cancer Discov"},{"issue":"1","key":"6393_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00262-020-02649-x","volume":"70","author":"R Cao","year":"2021","unstructured":"Cao R, Yuan L, Ma B, Wang G, Tian Y. Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC). Cancer Immunol Immunother. 2021;70(1):1\u201318.","journal-title":"Cancer Immunol Immunother"},{"key":"6393_CR55","doi-asserted-by":"publisher","first-page":"683940","DOI":"10.3389\/fcell.2021.683940","volume":"9","author":"Z Nie","year":"2021","unstructured":"Nie Z, Chen M, Wen X, Gao Y, Huang D, Cao H, Peng Y, Guo N, Ni J, Zhang S. Endoplasmic reticulum stress and tumor microenvironment in bladder cancer: the missing link. Front Cell Dev Biol. 2021;9:683940.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"6393_CR56","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/cac2.12416","volume":"43","author":"A Goenka","year":"2023","unstructured":"Goenka A, Khan F, Verma B, Sinha P, Dmello CC, Jogalekar MP, Gangadaran P, Ahn BC. Tumor microenvironment signaling and therapeutics in cancer progression. Cancer Commun (Lond). 2023;43(5):525\u201361.","journal-title":"Cancer Commun (Lond)"},{"issue":"4","key":"6393_CR57","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.cell.2016.12.004","volume":"168","author":"JR Cubillos-Ruiz","year":"2017","unstructured":"Cubillos-Ruiz JR, Bettigole SE, Glimcher LH. Tumorigenic and immunosuppressive effects of Endoplasmic reticulum stress in cancer. Cell. 2017;168(4):692\u2013706.","journal-title":"Cell"},{"issue":"6486","key":"6393_CR58","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1126\/science.aay2494","volume":"368","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Torres M, Sha H, Halbrook CJ, Van den Bergh F, Reinert RB, Yamada T, Wang S, Luo Y, Hunter AH, et al. Endoplasmic reticulum-associated degradation regulates mitochondrial dynamics in brown adipocytes. Science. 2020;368(6486):54\u201360.","journal-title":"Science"},{"issue":"25","key":"6393_CR59","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1038\/onc.2016.501","volume":"36","author":"M Gueguinou","year":"2017","unstructured":"Gueguinou M, Crottes D, Chantome A, Rapetti-Mauss R, Potier-Cartereau M, Clarysse L, Girault A, Fourbon Y, Jezequel P, Guerin-Charbonnel C, et al. The SigmaR1 chaperone drives breast and colorectal cancer cell migration by tuning SK3-dependent Ca(2+) homeostasis. Oncogene. 2017;36(25):3640\u20137.","journal-title":"Oncogene"},{"issue":"3","key":"6393_CR60","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1158\/0008-5472.CAN-15-1465","volume":"76","author":"D Crottes","year":"2016","unstructured":"Crottes D, Rapetti-Mauss R, Alcaraz-Perez F, Tichet M, Gariano G, Martial S, Guizouarn H, Pellissier B, Loubat A, Popa A, et al. SIGMAR1 regulates membrane electrical activity in response to extracellular matrix stimulation to drive cancer cell invasiveness. Cancer Res. 2016;76(3):607\u201318.","journal-title":"Cancer Res"},{"key":"6393_CR61","doi-asserted-by":"crossref","unstructured":"Chagas PS, Garcia CB, Sousa LO, da Silva G, Sousa GR, Marcelino RC, de Matos LL, Kowalski LP, Salles E, Wang L et al. SIGMAR1 knockdown enhances oral cancer cell chemosensitivity to cisplatin via decreased PD-L1 expression. Int J Mol Sci 2024, 25(22).","DOI":"10.3390\/ijms252211856"},{"issue":"4","key":"6393_CR62","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.1096\/fj.201901921R","volume":"34","author":"I Bravo-Caparros","year":"2020","unstructured":"Bravo-Caparros I, Ruiz-Cantero MC, Perazzoli G, Cronin SJF, Vela JM, Hamed MF, Penninger JM, Baeyens JM, Cobos EJ, Nieto FR. Sigma-1 receptors control neuropathic pain and macrophage infiltration into the dorsal root ganglion after peripheral nerve injury. FASEB J. 2020;34(4):5951\u201366.","journal-title":"FASEB J"},{"issue":"1","key":"6393_CR63","doi-asserted-by":"publisher","first-page":"2455722","DOI":"10.1080\/15384047.2025.2455722","volume":"26","author":"PA Castagnino","year":"2025","unstructured":"Castagnino PA, Haas DA, Musante L, Tancler NA, Tran BV, Kean R, Steck AR, Martinez LA, Mostaghel EA, Hooper DC, et al. Sigma1 inhibitor suppression of adaptive immune resistance mechanisms mediated by cancer cell derived extracellular vesicles. Cancer Biol Ther. 2025;26(1):2455722.","journal-title":"Cancer Biol Ther"},{"key":"6393_CR64","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3389\/fphar.2019.01141","volume":"10","author":"HM Oyer","year":"2019","unstructured":"Oyer HM, Sanders CM, Kim FJ. Small-Molecule modulators of Sigma1 and Sigma2\/TMEM97 in the context of cancer: foundational concepts and emerging themes. Front Pharmacol. 2019;10:1141.","journal-title":"Front Pharmacol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06393-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06393-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06393-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:10:11Z","timestamp":1757160611000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06393-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6393"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06393-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients have signed an informed consent form, and the study protocol has acquired official approval from the Medical Ethics Committee of the Shanghai General Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors of this article agree to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"417"}}